Bob Dagher

Hoofd Techniek/Wetenschap/O&O bij BRAINSTORM CELL THERAPEUTICS INC.

Vermogen: 123 211 $ op 31-05-2024

55 jaar

Health Technology

Consumer Services

Actieve functies van Bob Dagher

Bedrijven	Functie	Begin	Einde
BRAINSTORM CELL THERAPEUTICS INC.	Hoofd Techniek/Wetenschap/O&O	16-04-2024	-
BRAINSTORM CELL THERAPEUTICS INC.	Corporate Officer/Principal	17-07-2023	16-04-2024

Bedrijven	Functie	Begin	Einde
ENVERIC BIOSCIENCES, INC.	Hoofd Techniek/Wetenschap/O&O	06-12-2021	01-01-2023
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01-12-2019	01-12-2021
COVANCE INC.	Hoofd Techniek/Wetenschap/O&O	01-01-2018	01-01-2019
MedAvante-ProPhase, Inc.	Hoofd Techniek/Wetenschap/O&O	-	-

Faculté De Médecine Necker Enfants Malades Université	Undergraduate Degree
Université de Bordeaux	Undergraduate Degree

Internationaal

Verenigde Staten	6
Frankrijk	3

Operationeel

Chief Tech/Sci/R&D Officer	4
Corporate Officer/Principal	2
Undergraduate Degree	2

Sectoraal

Health Technology	5
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
ENVERIC BIOSCIENCES, INC.	Health Technology
BRAINSTORM CELL THERAPEUTICS INC.	Health Technology

Bedrijven in privébezit	3
MedAvante-ProPhase, Inc.
Labcorp Drug Development, Inc. Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology